AAAAAA

   
Results: 1-14 |
Results: 14

Authors: Wilson, AM Sims, EJ Orr, LC Coutie, WJR White, PS Gardiner, Q Lipworth, BJ
Citation: Am. Wilson et al., Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis, ANN ALLER A, 87(4), 2001, pp. 344-349

Authors: Wilson, AM Dempsey, OJ Sims, EJ Lipworth, BJ
Citation: Am. Wilson et al., A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma, CLIN EXP AL, 31(4), 2001, pp. 616-624

Authors: Wilson, AM Orr, LC Sims, EJ Lipworth, BJ
Citation: Am. Wilson et al., Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis, CLIN EXP AL, 31(1), 2001, pp. 61-68

Authors: Fowler, SJ Orr, LC Wilson, AM Sims, EJ Lipworth, BJ
Citation: Sj. Fowler et al., Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate, BR J CL PH, 52(1), 2001, pp. 93-95

Authors: Wilson, AM Dempsey, OJ Sims, EJ Lipworth, BJ
Citation: Am. Wilson et al., Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids, CHEST, 119(4), 2001, pp. 1021-1026

Authors: Sims, EJ Newman, RB Hulsey, TC
Citation: Ej. Sims et al., Vaginal birth after cesarean: To induce or not to induce, AM J OBST G, 184(6), 2001, pp. 1122-1124

Authors: Wilson, AM Dempsey, OJ Sims, EJ Lipworth, BJ
Citation: Am. Wilson et al., Subjective and objective markers of treatment response in patients with seasonal allergic rhinitis, ANN ALLER A, 85(2), 2000, pp. 111-114

Authors: Wilson, AM Orr, LC Sims, EJ Dempsey, OJ Lipworth, BJ
Citation: Am. Wilson et al., Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma, AM J R CRIT, 162(4), 2000, pp. 1297-1301

Authors: Fowler, SJ Dempsey, OJ Sims, EJ Lipworth, BJ
Citation: Sj. Fowler et al., Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate - Relationship to asthma severity and beta(2)-receptor genotype, AM J R CRIT, 162(4), 2000, pp. 1318-1322

Authors: Wilson, A Dempsey, OJ Sims, EJ Coutie, WJR Paterson, MC Lipworth, BJ
Citation: A. Wilson et al., Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow, CLIN EXP AL, 30(6), 2000, pp. 833-838

Authors: Dempsey, OJ Wilson, AM Sims, EJ Mistry, C Lipworth, BJ
Citation: Oj. Dempsey et al., Additive bronchoprotective and bronchodilator effects with single doses ofsalmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids, CHEST, 117(4), 2000, pp. 950-953

Authors: Wilson, AM Sims, EJ Lipworth, BJ
Citation: Am. Wilson et al., Dose response with fluticasone propionate on adrenocortical activity and recovery of basal and stimulated responses after stopping treatment, CLIN ENDOCR, 50(3), 1999, pp. 329-335

Authors: Wilson, AM Sims, EJ Orr, LC Lipworth, BJ
Citation: Am. Wilson et al., Differences in lung bioavailability between different propellants for fluticasone propionate, LANCET, 354(9187), 1999, pp. 1357-1358

Authors: Wilson, AM Dempsey, OJ Coutie, WJR Sims, EJ Lipworth, BJ
Citation: Am. Wilson et al., Importance of drug-device interaction in determining systemic effects of inhaled corticosteroids, LANCET, 353(9170), 1999, pp. 2128-2128
Risultati: 1-14 |